Your browser doesn't support javascript.
loading
Immune-related gigantomastia: a case study.
Lozito, Alessia; Gemelli, Maria; Micello, Donata; Vinci, Valeriano; Pelosi, Giuseppe; Ricotta, Riccardo.
Afiliação
  • Lozito A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, 20090, Italy.
  • Gemelli M; Medical Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, 20099, Italy.
  • Micello D; Inter-Hospital Division of Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy.
  • Vinci V; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, 20090, Italy.
  • Pelosi G; Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy.
  • Ricotta R; Inter-Hospital Division of Pathology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy.
Immunotherapy ; 15(13): 1001-1007, 2023 09.
Article em En | MEDLINE | ID: mdl-37431623
A person with a type of lung cancer called non-small-cell lung cancer might get treated with a special drug called nivolumab. This drug helps the body's immune system fight the cancer. However, even though these new drugs work well, they can sometimes cause side effects. Some of these side effects are very rare and hard to predict. In one case, a patient who took nivolumab developed a condition called gigantomastia. This means their breasts became unusually large. The doctors checked for other possible causes, but couldn't find any. Gigantomastia is already a very rare condition by itself. What's even more interesting is that nobody has ever reported gigantomastia as a side effect of immunological therapies before. Researchers still don't know why it happened in this case. This episode is worth mentioning because it's a very unusual and unique case.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Immunotherapy Assunto da revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nivolumabe / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Immunotherapy Assunto da revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
...